Literature DB >> 12095471

Nausea and Vomiting.

Xose Fernández Fraga1, Juan R. Malagelada.   

Abstract

Nausea and vomiting are rather stereotyped symptoms. The challenge is that nausea and vomiting have many different causes and, in some patients, management may be rather complex. The clue is to determine the causal factor early. It helps to separate acute vomiting (<48 hours onset) from chronic vomiting. In acute vomiting, the causal factor or factors are most often evident. Symptomatic treatment with parenteral central-type antiemetics is the preferred treatment. Histamine-1 receptor antagonists, phenothiazines, butyrophenones, and corticosteroids are suitable drugs. For specific types of acute vomiting, for example, chemotherapy-related vomiting, the 5-HT3 receptor antagonists are costlier but effective drugs with minimal side effects. Sometimes, oral and parenteral administration of the above-mentioned drugs may be combined. The origin of chronic vomiting is often obscure, requires specialized investigation, and the causative factor may be uncorrectable. Symptomatic treatment requires a value judgement. If delayed gastric emptying is a contributing factor, prokinetic agents (metoclopramide, erythromycin, cisapride in special cases, if authorized) may prove useful. Otherwise, symptomatic treatment with central antiemetics is the only recourse. Some patients with unexplained vomiting present with psychological disturbances that act as magnifying or contributing factors and may be helped by psychotherapeutics.

Entities:  

Year:  2002        PMID: 12095471     DOI: 10.1007/s11938-002-0046-6

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  26 in total

1.  Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.

Authors:  R J Gralla; D Osoba; M G Kris; P Kirkbride; P J Hesketh; L W Chinnery; R Clark-Snow; D P Gill; S Groshen; S Grunberg; J M Koeller; G R Morrow; E A Perez; J H Silber; D G Pfister
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

2.  A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis.

Authors:  E Zarate; M F Watcha; P F White; K W Klein; M Sa Rego; D G Stewart
Journal:  Anesth Analg       Date:  2000-06       Impact factor: 5.108

Review 3.  Review article: the continuing dilemma of dyspepsia.

Authors:  J R Malagelada
Journal:  Aliment Pharmacol Ther       Date:  2001-06       Impact factor: 8.171

4.  Rumination.

Authors:  Kevin W. Olden
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

5.  Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis.

Authors:  K B Domino; E A Anderson; N L Polissar; K L Posner
Journal:  Anesth Analg       Date:  1999-06       Impact factor: 5.108

6.  Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo.

Authors:  R P Hill; D A Lubarsky; B Phillips-Bute; J T Fortney; M R Creed; P S Glass; T J Gan
Journal:  Anesthesiology       Date:  2000-04       Impact factor: 7.892

7.  The prognosis of cyclical vomiting syndrome.

Authors:  F Dignan; D N Symon; I AbuArafeh; G Russell
Journal:  Arch Dis Child       Date:  2001-01       Impact factor: 3.791

8.  Similarities in cyclic vomiting syndrome across age groups.

Authors:  C Prakash; A Staiano; R J Rothbaum; R E Clouse
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

9.  Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret.

Authors:  M D Van Sickle; L D Oland; W Ho; C J Hillard; K Mackie; J S Davison; K A Sharkey
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

10.  Treatment of established postoperative nausea and vomiting: a quantitative systematic review.

Authors:  Faranak Kazemi-Kjellberg; Iris Henzi; Martin R Tramèr
Journal:  BMC Anesthesiol       Date:  2001       Impact factor: 2.217

View more
  1 in total

1.  The role of electrogastrography and gastrointestinal hormones in chemotherapy-related dyspeptic symptoms.

Authors:  Giuseppe Riezzo; Caterina Clemente; Silvana Leo; Francesco Russo
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.